Genetically Engineered Hypoimmunogenic Cell Therapy

The authors discuss key advances and challenges in the clinical translation of hypoimmunogenic cells and describes the genetic engineering methods and manufacturing processes used to create hypoimmunogenic therapeutic cells, while highlighting the complexity of relevant immunological pathways.